Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amag Pharmaceuticals
(NQ:
AMAG
)
13.75
USD
UNCHANGED
Last Price
Updated: 4:06 PM EST, Nov 13, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Amag Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
50
51
Next >
Thinking about buying stock in Aurora Cannabis, AMAG Pharmaceuticals, Minerva Neurosciences, Palatin Technologies, or Zoom Video Communications?
June 24, 2019
InvestorsObserver issues critical PriceWatch Alerts for ACB, AMAG, NERV, PTN, and ZM.
From
PR Newswire
34 Stocks Moving In Monday's Pre-Market Session
June 24, 2019
Gainers PCM, Inc. (NASDAQ: PCMI) shares rose 41.8% to $34.57 in pre-market trading after Insight announced plans to acquire PCM ...
Tags
Losers
AZO
TCCO
From
Benzinga
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
June 22, 2019
Biotech stocks came made upward moveslast week after a rangebound period. Among big pharma companies, Merck & Co., ...
Tags
RHHBY
MRK
ASND
From
Benzinga
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi™ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
June 21, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that the U.S. Food and Drug Administration (FDA) has approved Vyleesi™ (bremelanotide injection), a melanocortin receptor agonist, to treat...
From
GlobeNewswire News Releases
FDA approves drug for loss of female sexual desire
June 21, 2019
The U.S. Food and Drug Administration on Friday approved Palatin Technologies Inc and Amag Pharmaceuticals Inc's drug to restore sexual desire in premenopausal women, Amag said.
Tags
companyNews
From
Reuters: Company News
The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy
June 21, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
HOLX
ANIP
TROV
From
Benzinga
Noteworthy Wednesday Option Activity: NVTA, ETN, AMAG
June 19, 2019
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Invitae Corp (NVTA), where a total volume of 6,067 contracts has been traded thus...
Tags
Stocks
From
Market News Video
Downtrend Call Working As Amag Pharmaceuti Stock Falls 50.5% (AMAG)
June 19, 2019
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 8 months, Amag Pharmaceuti has returned 50.48% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
RWJ's Underlying Holdings Could Mean 24% Gain Potential
June 17, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
46.8% Return Seen to Date on SmarTrend Amag Pharmaceuti Call (AMAG)
June 12, 2019
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 7 months, Amag Pharmaceuti has returned 46.79% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
Jim Cramer Shares His Thoughts On AMD, CME Group, Microsoft And More
June 05, 2019
Jim Cramer said on CNBC's "Mad Money Lightning Round" that AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is way too ...
Tags
Market News
ADBE
Jim Cramer
From
Benzinga
3 Drug Stocks That Could Win From Key FDA Approvals in June
June 04, 2019
Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.
Tags
MRK
PTN
AMAG
From
Motley Fool
The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug
May 30, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
AXGT
NVIV
IMRN
From
Benzinga
AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
May 29, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the Jefferies 2019 Global Healthcare Conference in New York City on...
From
GlobeNewswire News Releases
Amag Pharmaceuti Has Returned 42.8% Since SmarTrend Recommendation (AMAG)
May 28, 2019
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 7 months, Amag Pharmaceuti has returned 42.76% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails
May 21, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
AKCA
MNK
NVTR
From
Benzinga
AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York
May 17, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019 from 8:30 a.m. to 12:00 p.m. Eastern Time. Members of...
From
GlobeNewswire News Releases
Amag Pharmaceuti Down 38.5% Since SmarTrend Downtrend Call (AMAG)
May 09, 2019
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 6 months, Amag Pharmaceuti has returned 38.46% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split
May 08, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
SGMO
RVNC
VSTM
From
Benzinga
72 Biggest Movers From Yesterday
May 08, 2019
Gainers Bridgeline Digital Inc (NASDAQ: BLIN) shares surged 24.76 percent to close at $7.71 after the company announced a ...
Tags
Losers
Sprucepoint Capital
MBRX
From
Benzinga
AMAG Pharmaceuticals Inc (AMAG) Q1 2019 Earnings Call Transcript
May 07, 2019
AMAG earnings call for the period ending March 31, 2019.
Tags
AMAG
Market News
From
Motley Fool
64 Stocks Moving In Tuesday's Mid-Day Session
May 07, 2019
Gainers Bridgeline Digital Inc (NASDAQ: BLIN) shares climbed 32.8 percent to $8.20 after the company announced a ...
Tags
Movers
VECO
AVID
From
Benzinga
The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex
May 07, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
HALO
ETON
IOVA
From
Benzinga
AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
May 07, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the first quarter ended March 31, 2019 and provided a business update.
From
GlobeNewswire News Releases
AMAG Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual Meeting
May 03, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it will present new data related to investigational drug bremelanotide for the treatment of hypoactive sexual desire disorder (HSDD) and...
From
GlobeNewswire News Releases
Amag Pharmaceuti Shares Down 37.7% Since SmarTrend's Sell Call (AMAG)
May 01, 2019
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 6 months, Amag Pharmaceuti has returned 37.73% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
Interesting AMAG Put And Call Options For June 21st
April 30, 2019
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options become available this week, for the June 21st expiration..
Tags
Stocks
From
Market News Video
AMAG Pharmaceuticals to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019 at 8:00 a.m. ET
April 30, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019 before the U.S. financial markets open. Management will...
From
GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)
April 30, 2019
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an option to purchase 15,000 shares of common stock and...
From
GlobeNewswire News Releases
Amag Pharmaceuti Has Returned 33.3% Since SmarTrend Recommendation (AMAG)
April 24, 2019
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 6 months, Amag Pharmaceuti has returned 33.31% as of today's recent price of...
From
Comtex SmarTrend® News Briefs
< Previous
1
2
3
4
5
6
7
8
9
...
50
51
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.